Skip to content Skip to menu

Central Database Working Group

Progress Report

A Centralised Reporting System for Medicines Australia Member Companies’ Payments and Transfers of Value to Health Care Professionals

Background

On 24 April 2015 the ACCC issued its final determination granting conditional authorisation of Edition 18 of the Medicines Australia Code of Conduct for a period of five years. The authorisation became effective on 16 May 2015.

A condition of the authorisation is that Medicines Australia must use reasonable endeavours to develop and implement a Central Reporting System (CRS) which will allow the public to access information on payments and transfers of value from all companies to healthcare professionals in a single location, via the internet. This condition also requires Medicines Australia to provide regular six-monthly reports identifying the steps taken each reporting period to develop and/or implement a CRS.

Establishing a Centralised Reporting System

Since the last progress report published in May 2019, we have undertaken the following work. Medicines Australia continues to assist and advise member companies in preparing their information about reportable payments and transfers of value to individual healthcare professionals.

CRS Development

Pacific Commerce engaged with Medicines Australia’s member companies during May – June 2019 to test the finalised reporting system in readiness to include data from the reporting round of 1 November 2018 – 30 April 2019.

The Central Reporting System went live on 30 August 2019, with the input of data from thirty-two Medicines Australia Member Companies.

This database is available from its new website:

https://disclosureaustralia.com.au

Seventh Transparency Reports

The seventh reports, relating to activities occurring between 1 November 2018 and 30 April 2019, were the first reports to be published by member companies through the new central reporting system on 30 August 2019. Thirty-two member companies published reports in the CRS as well as on their company websites. These reports are hyperlinked from the Medicines Australia website.

This was the fifth, full six-month reporting period where healthcare professionals reasonably expected their data to be published.  This was the first reporting period where data had been published in the central reporting system.  A number of activities were excluded due to being contracted before an updated collection statement was in place referring to the central reporting system and therefore some healthcare professional did not have the expectation that their data would be published in a centralised database. This constituted less than 5% of the total reports published.  It is expected that this number will continue to reduce dramatically with each ongoing publication.

Searches

As at time of reporting, this database has been searched in excess of 5,000 times including searches for individual healthcare professionals by name, profession, type of service and location. 

Next steps

This is the final report on the development of the central reporting system, as the website is now live. Medicines Australia remains committed to transparency measures and will continue to monitor and support https://disclosureaustralia.com.au

15 November 2019

Downloadable PDF is also available.

Previous Reports

Top